Jason P Rhodes

Director, Dyne Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$129M

Companies

Latest trade

Aug 14, 2026

Companies

Dyne Therapeutics, Inc.Director −$129M

Trades

DYN Sold 2,160,516 shares at $25.00 · planned $54.0M Aug 14

DYN Sold 426,412 shares at $26.20 · planned $11.2M Aug 13

DYN Sold 297,211 shares at $23.26 · planned $6.9M Jul 7

DYN Sold 480,240 shares at $22.79 · planned $10.9M Jul 6

DYN Sold 195,427 shares at $21.14 · planned $4.1M Jun 29

DYN Sold 309,268 shares at $21.28 · planned $6.6M Jun 26

DYN Sold 24,100 shares at $21.10 · planned $0.5M Jun 25

DYN Sold 95,900 shares at $21.02 · planned $2.0M Jun 24

DYN Sold 147,760 shares at $21.13 · planned $3.1M Jun 23

DYN Sold 83,219 shares at $18.18 · planned $1.5M May 6

DYN Sold 11,600 shares at $18.03 · planned $0.2M May 5

DYN Sold 11,904 shares at $18.00 · planned $0.2M May 4

DYN Sold 227,337 shares at $18.38 · planned $4.2M Apr 28

DYN Sold 173,493 shares at $18.15 · planned $3.1M Apr 27

DYN Sold 137,948 shares at $18.48 · planned $2.5M Apr 24

DYN Sold 73,108 shares at $19.19 · planned $1.4M Apr 23

DYN Sold 287,956 shares at $19.68 · planned $5.7M Apr 22

DYN Sold 274,297 shares at $19.52 · planned $5.4M Apr 21

DYN Sold 272,049 shares at $20.06 · planned $5.5M Apr 20

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.